The latest price target for Core Laboratories (NYSE:CLB) was reported by Citigroup on March 12, 2025. The analyst firm set a price target for $16.00 expecting CLB to rise to within 12 months (a possible 7.02% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Core Laboratories (NYSE:CLB) was provided by Citigroup, and Core Laboratories upgraded their neutral rating.

The last upgrade for Core Laboratories Inc happened on March 12, 2025 when Citigroup raised their price target to $16. Citigroup previously had a sell for Core Laboratories Inc.

The last downgrade for Core Laboratories Inc happened on June 30, 2023 when Citigroup changed their price target from $22 to $21 for Core Laboratories Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.

While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a upgraded with a price target of $15.00 to $16.00. The current price Core Laboratories (CLB) is trading at is $14.95, which is out of the analyst’s predicted range.